josefkubes
- Chinese regulators have approved Icotyde, a once-daily pill developed by Johnson & Johnson (JNJ) and Protagonist Therapeutics (PTGX) as a treatment for plaque psoriasis, a skin-related autoimmune disease, according to a company statement.
- China’s National Medical Products Administration approved Icotyde
